Williams Jones & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$11.6M Buy
63,173
+51
+0.1% +$9.13K 0.24% 75
2019
Q1
$12M Sell
63,122
-2,580
-4% -$493K 0.27% 73
2018
Q4
$12.8M Buy
65,702
+240
+0.4% +$46.8K 0.35% 66
2018
Q3
$13.6M Sell
65,462
-40
-0.1% -$7.88K 0.27% 80
2018
Q2
$12.1M Sell
65,502
-700
-1% -$124K 0.27% 81
2018
Q1
$11.3M Sell
66,202
-2,172
-3% -$399K 0.26% 84
2017
Q4
$11.9M Buy
68,374
+97
+0.1% +$17.2K 0.27% 82
2017
Q3
$12.7M Buy
68,277
+930
+1% +$165K 0.31% 72
2017
Q2
$11.6M Sell
67,347
-372
-0.5% -$60.5K 0.29% 75
2017
Q1
$11.1M Buy
67,719
+322
+0.5% +$53.5K 0.29% 79
2016
Q4
$9.85M Sell
67,397
-4,234
-6% -$637K 0.28% 84
2016
Q3
$11.9M Buy
71,631
+200
+0.3% +$33.8K 0.35% 70
2016
Q2
$10.9M Buy
71,431
+57,132
+400% +$8.88M 0.34% 76
2016
Q1
$2.14M Buy
14,299
+550
+4% +$81.7K 0.1% 126
2015
Q4
$2.23M Buy
13,749
+3,459
+34% +$544K 0.1% 125
2015
Q3
$1.42M Sell
10,290
-550
-5% -$86.7K 0.06% 159
2015
Q2
$1.66M Sell
10,840
-288
-3% -$46.1K 0.06% 162
2015
Q1
$1.78M Buy
11,128
+950
+9% +$150K 0.07% 161
2014
Q4
$1.62M Buy
10,178
+1,355
+15% +$211K 0.07% 164
2014
Q3
$1.24M Sell
8,823
-352
-4% -$46K 0.06% 158
2014
Q2
$1.09M Sell
9,175
-10,075
-52% -$1.17M 0.05% 161
2014
Q1
$2.37M Buy
19,250
+9,625
+100% +$1.17M 0.05% 173
2013
Q4
$1.1M Buy
9,625
+239
+3% +$27.2K 0.05% 142
2013
Q3
$1.05M Buy
9,386
+711
+8% +$77.1K 0.05% 145
2013
Q2
$856K Buy
+8,675
New +$900K 0.04% 181

Other funds holding AMGN

Williams Jones & Associates's AMGN Position: Q2 2019 in Review

Williams Jones & Associates increased its Amgen (AMGN) stake by 0.08% in Q2 2019, buying an estimated $9.13K and bringing the position to 63,173 shares worth $11.6M. The position accounts for 0.24% of the portfolio, ranked #75.

Williams Jones & Associates first reported a position in AMGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $13.6M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Williams Jones & Associates held 63,173 shares of Amgen worth $11.6M as of Q2 2019.
  • Williams Jones & Associates bought 51 Amgen shares in Q2 2019, an estimated $9.13K.
  • Amgen made up 0.24% of Williams Jones & Associates's portfolio in Q2 2019, its #75 holding.
  • Williams Jones & Associates first reported a position in Amgen in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Amgen position peaked at $13.6M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.